欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DK/H/0899/002
药品名称Lafunomyl
活性成分
    • alfuzosin hydrochloride 10.0 mg
剂型Prolonged-release tablet
上市许可持有人Viatris Limited Damastown Industrial Park Mulhuddart Dublin 15 Ireland
参考成员国 - 产品名称Denmark (DK)
Lafunomyl
互认成员国 - 产品名称
    • Netherlands (NL)
      Alfuzosine HCL Retard mylan 10 mg
    • Spain (ES)
    • Ireland (IE)
    • Portugal (PT)
    • Sweden (SE)
    • Czechia (CZ)
    • Slovakia (SK)
      Alfuzosin Mylan 10 mg
    • Italy (IT)
许可日期2006/03/23
最近更新日期2024/04/03
药物ATC编码
    • G04CA01 alfuzosin
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase